Latest Period
Q1 2026
Security Snapshot
GSK plc - SPONSORED ADR (GSK) Institutional Ownership
CUSIP: 37733W204
13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026
Institutions Reporting
1,018
Shares (Excl. Options)
374,202,866
Price
$55.19
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / SPONSORED ADR
- Symbol
- GSK on NYSE
- Price per share
- $54.47
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 374,202,866
- Total reported value
- $20,653,546,250
- % of total 13F portfolios
- 0.02%
- Share change
- -22,611,887
- Value change
- -$1,219,682,333
- Number of holders
- 1,018
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- GSK - GSK plc - SPONSORED ADR is tracked under CUSIP 37733W204.
- 1018 institutions reported positions in Q1 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 988 to 1,018 between Q4 2025 and Q1 2026.
- Reported value moved from $19,505,732,223 to $20,653,546,250.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 1018 institutions filings for Q1 2026.
Security key
37733W204
Latest holder period
Q1 2026
13F holders
1,018
13D/G owners
0
CIK / CUSIP context first
Open Q1 2026 holders
GSK full holder history
GSK plc SEC filings
GSK plc company facts
GSK plc 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 37733W204:
As of 31 Mar 2026, 1,018 institutional investors reported holding 374,202,866 shares of GSK plc - SPONSORED ADR (GSK).
Institutional Holders of GSK plc - SPONSORED ADR (GSK) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 374,202,866 | $20,653,546,250 | -$1,219,682,333 | $55.19 | 1,018 |
| 2025 Q4 | 397,706,471 | $19,505,732,223 | +$560,994,497 | $49.04 | 988 |
| 2025 Q3 | 385,810,445 | $16,653,456,346 | +$149,628,861 | $43.16 | 883 |
| 2025 Q2 | 377,323,511 | $14,492,600,704 | +$691,641,935 | $38.40 | 873 |
| 2025 Q1 | 365,061,086 | $14,138,125,686 | +$1,006,993,911 | $38.74 | 839 |
| 2024 Q4 | 340,917,752 | $11,541,588,389 | +$1,180,300,325 | $33.82 | 833 |
| 2024 Q3 | 302,968,498 | $12,377,977,607 | -$140,106,119 | $40.88 | 883 |
| 2024 Q2 | 309,126,756 | $11,909,339,872 | -$23,346,819 | $38.50 | 869 |
| 2024 Q1 | 308,583,941 | $13,222,947,461 | +$833,173,631 | $42.87 | 891 |
| 2023 Q4 | 289,484,844 | $10,732,131,887 | +$174,194,109 | $37.06 | 882 |
| 2023 Q3 | 284,245,298 | $10,307,406,122 | +$264,432,361 | $36.25 | 835 |
| 2023 Q2 | 276,495,626 | $9,857,311,052 | +$194,467,459 | $35.64 | 814 |
| 2023 Q1 | 269,710,676 | $9,600,329,935 | -$208,079,525 | $35.58 | 792 |
| 2022 Q4 | 276,203,256 | $9,708,565,984 | +$516,369,806 | $35.14 | 788 |
| 2022 Q3 | 264,324,002 | $7,785,299,734 | +$7,652,922,694 | $29.43 | 697 |
| 2022 Q2 | 4,250,301 | $185,367,037 | +$183,087,502 | $43.53 | 67 |
| 2022 Q1 | 52,302 | $2,281,067 | -$356,058 | $43.56 | 7 |
| 2021 Q4 | 60,336 | $2,667,168 | -$139,973 | $44.10 | 7 |
| 2021 Q3 | 17,405 | $671,931 | +$7,790 | $38.21 | 6 |
| 2021 Q2 | 17,188 | $691,875 | -$30,222 | $39.82 | 6 |
| 2021 Q1 | 17,949 | $649,577 | +$393,265 | $35.69 | 6 |
| 2020 Q4 | 7,178 | $264,151 | -$29,072 | $36.80 | 4 |
| 2020 Q3 | 7,968 | $299,261 | +$325 | $37.64 | 4 |
| 2020 Q2 | 7,971 | $325,296 | -$17,284 | $40.79 | 3 |
| 2020 Q1 | 8,394 | $316,305 | -$7,502 | $37.89 | 3 |
| 2019 Q4 | 8,592 | $403,759 | +$47 | $46.99 | 3 |
| 2019 Q3 | 6,012 | $256,603 | +$43 | $42.68 | 2 |
| 2019 Q2 | 6,011 | $240,560 | +$280 | $40.02 | 2 |
| 2019 Q1 | 6,004 | $250,926 | -$58,469 | $41.79 | 2 |
| 2018 Q4 | 7,403 | $282,874 | -$23,957 | $38.21 | 2 |
| 2018 Q3 | 8,030 | $322,558 | -$357,464 | $40.17 | 2 |
| 2018 Q2 | 16,929 | $682,392 | +$81 | $40.31 | 2 |
| 2018 Q1 | 16,927 | $661,338 | +$10,158 | $39.07 | 2 |
| 2017 Q4 | 16,667 | $591,179 | -$47,282 | $35.47 | 2 |
| 2017 Q3 | 18,000 | $730,800 | -$109,620 | $40.60 | 2 |
| 2017 Q2 | 20,700 | $892,584 | $43.12 | 2 | |
| 2017 Q1 | 20,700 | $872,712 | $42.16 | 2 | |
| 2016 Q4 | 20,700 | $797,157 | +$182,191 | $38.51 | 2 |
| 2016 Q3 | 15,969 | $688,743 | +$10,783 | $43.13 | 2 |
| 2016 Q2 | 15,719 | $681,261 | -$56,342 | $43.34 | 2 |
| 2016 Q1 | 17,019 | $690,120 | $40.55 | 2 |